Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. reported $36K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Baxter International BAX:US USD 683M 0
Cerus CERS:US USD 180K 3K
Haemonetics HAE:US USD 504K 0
Infinity Pharmaceuticals INFI:US USD 89K 0
Merrimack Pharmaceuticals MACK:US USD 1.34M 1000
Mirati Therapeutics MRTX:US USD 58K 0
Northwest Biotherapeutics NWBO:US USD 1.08M 15K
Plus Therapeutics, Inc. CYTX:US USD 36K 2K
Starpharma Holdings Ltd SPL:AU AUD 240.67M 0
Teva Pharmaceutical Industries Ltd TEVA:IT USD 57M 0